GlassScriptPhysician profile
Aisha Siddiqui
NPI 1972713386
$3,860.42
in general payments reported to CMS, 2019-2025
14 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,009 · 2020: $17.75 · 2021: $19.60 · 2022: $779 · 2023: $820 · 2024: $33.16 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $674 · Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $674.39 |
| Food and Beverage | $361.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,385.50 | 2019-2023 | Da Vinci Surgical System |
| Baxter Healthcare | $123.81 | 2022 | |
| Abbvie INC. | $75.30 | 2019-2025 | |
| Astellas Pharma US INC | $73.91 | 2023-2025 | Veozah |
| Organon LLC | $33.16 | 2024 | |
| Lilly USA, LLC | $23.53 | 2025 | Zepbound, Mounjaro |
| Millicent US INC | $19.97 | 2025 | Femlyv |
| Optos, INC. | $19.60 | 2021 | |
| Sumitomo Pharma America, INC. | $18.96 | 2025 | Gemtesa |
| Pfizer INC. | $18.74 | 2023 | |
| Exeltis, USA INC. | $18.45 | 2025 | Slynd |
| Neurocrine Biosciences, INC. | $17.75 | 2020 | |
| Merck Sharp & Dohme LLC | $17.17 | 2025 | Bridion |
| Olympus America INC. | $14.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aisha Siddiqui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.